Cargando…
Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion
BACKGROUND: Pleural effusion (PE) is presenting symptoms of many different diseases and is often a diagnostic challenge. Negative cytology in the malignant PE requires more complicated diagnostic procedures, such as closed pleural biopsy or thoracoscopic pleural biopsy. Not all the patients will be...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098895/ https://www.ncbi.nlm.nih.gov/pubmed/33687007 http://dx.doi.org/10.4103/lungindia.lungindia_196_20 |
_version_ | 1783688496381165568 |
---|---|
author | Krishnan, Vishnu G Kunoor, Akhilesh Keechilath, Pavithran Mehta, Asmita Anilkumar |
author_facet | Krishnan, Vishnu G Kunoor, Akhilesh Keechilath, Pavithran Mehta, Asmita Anilkumar |
author_sort | Krishnan, Vishnu G |
collection | PubMed |
description | BACKGROUND: Pleural effusion (PE) is presenting symptoms of many different diseases and is often a diagnostic challenge. Negative cytology in the malignant PE requires more complicated diagnostic procedures, such as closed pleural biopsy or thoracoscopic pleural biopsy. Not all the patients will be fit for such invasive procedures due to high risk. Tumor markers seem to be a promising alternative and have been proposed to aid in the differentiation of the PE etiology. OBJECTIVE: The objective of the study was to evaluate the diagnostic value of pleural fluid carcinoembryonic antigen (CEA) in differentiation between malignant and nonmalignant PEs and to compare adenosine deaminase (ADA) levels with respect to malignant and nonmalignant PE. METHODOLOGY: It was a prospective observational study. Patients who presented with undiagnosed exudative PE during the time period 2016–2018 were studied. Pleural fluid was subjected to all routine investigations such as sugar, protein, lactate dehydrogenase, ADA, and CEA. RESULTS: A total of 100 patients were included in the study. Fifty-one patients had malignancy. Univariate analysis showed that smoker, previous history of cancer, ADA <20, and CEA of >2.15 were variables associated with malignancy. Multivariate analysis showed pleural fluid CEA >2.15 as only independent risk factor associated with malignancy. The sensitivity of 91.5% and 65% and specificity of 92.5% and 81.4%, respectively, were found for CEA 2.15 ng/dl and ADA <16.5 U/L as plotted from receiver operating characteristic curve. The combined CEA and ADA (2.39 ng/ml and 16.5 U/L) values in pleural fluid had higher sensitivity of 100%. CONCLUSION: Our study demonstrated that pleural fluid CEA levels have a sensitivity of 93.5% and specificity of 73% in diagnosing of malignant PE. ADA levels lesser than 16.5 U/L were seen in patients with malignant PE, but less sensitive and specific compared to CEA. Combined ADA and CEA levels had higher sensitivity than CEA alone. |
format | Online Article Text |
id | pubmed-8098895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-80988952021-05-07 Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion Krishnan, Vishnu G Kunoor, Akhilesh Keechilath, Pavithran Mehta, Asmita Anilkumar Lung India Original Article BACKGROUND: Pleural effusion (PE) is presenting symptoms of many different diseases and is often a diagnostic challenge. Negative cytology in the malignant PE requires more complicated diagnostic procedures, such as closed pleural biopsy or thoracoscopic pleural biopsy. Not all the patients will be fit for such invasive procedures due to high risk. Tumor markers seem to be a promising alternative and have been proposed to aid in the differentiation of the PE etiology. OBJECTIVE: The objective of the study was to evaluate the diagnostic value of pleural fluid carcinoembryonic antigen (CEA) in differentiation between malignant and nonmalignant PEs and to compare adenosine deaminase (ADA) levels with respect to malignant and nonmalignant PE. METHODOLOGY: It was a prospective observational study. Patients who presented with undiagnosed exudative PE during the time period 2016–2018 were studied. Pleural fluid was subjected to all routine investigations such as sugar, protein, lactate dehydrogenase, ADA, and CEA. RESULTS: A total of 100 patients were included in the study. Fifty-one patients had malignancy. Univariate analysis showed that smoker, previous history of cancer, ADA <20, and CEA of >2.15 were variables associated with malignancy. Multivariate analysis showed pleural fluid CEA >2.15 as only independent risk factor associated with malignancy. The sensitivity of 91.5% and 65% and specificity of 92.5% and 81.4%, respectively, were found for CEA 2.15 ng/dl and ADA <16.5 U/L as plotted from receiver operating characteristic curve. The combined CEA and ADA (2.39 ng/ml and 16.5 U/L) values in pleural fluid had higher sensitivity of 100%. CONCLUSION: Our study demonstrated that pleural fluid CEA levels have a sensitivity of 93.5% and specificity of 73% in diagnosing of malignant PE. ADA levels lesser than 16.5 U/L were seen in patients with malignant PE, but less sensitive and specific compared to CEA. Combined ADA and CEA levels had higher sensitivity than CEA alone. Wolters Kluwer - Medknow 2021 2021-03-02 /pmc/articles/PMC8098895/ /pubmed/33687007 http://dx.doi.org/10.4103/lungindia.lungindia_196_20 Text en Copyright: © 2021 Indian Chest Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Krishnan, Vishnu G Kunoor, Akhilesh Keechilath, Pavithran Mehta, Asmita Anilkumar Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion |
title | Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion |
title_full | Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion |
title_fullStr | Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion |
title_full_unstemmed | Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion |
title_short | Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion |
title_sort | diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098895/ https://www.ncbi.nlm.nih.gov/pubmed/33687007 http://dx.doi.org/10.4103/lungindia.lungindia_196_20 |
work_keys_str_mv | AT krishnanvishnug diagnosticutilityofpleuralfluidcarcinoembryonicantigeninpatientswithexudativepleuraleffusion AT kunoorakhilesh diagnosticutilityofpleuralfluidcarcinoembryonicantigeninpatientswithexudativepleuraleffusion AT keechilathpavithran diagnosticutilityofpleuralfluidcarcinoembryonicantigeninpatientswithexudativepleuraleffusion AT mehtaasmitaanilkumar diagnosticutilityofpleuralfluidcarcinoembryonicantigeninpatientswithexudativepleuraleffusion |